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Abstract
Grapes (Vitis spp.) are consumed as fresh table fruits, raisins, and processed into wine, 
juice, jelly and other value-added products. Grapes contain bioactive secondary metabo-
lites (polyphenols), such as proanthocyanins (oliogemeric flavonoids), flavonoids (cat-
echin, epicatechin, and quercetin), and anthocyanins. They have non-flavonoids such as 
hydroxycinnamic acids (p-coumaric, cinnamic, caffeic, gentisic, ferulic, and vanillic acids), 
and hydroxybenzoic acids: trihydroxy stilbenes (resveratrol and polydatin). These phyto-
chemicals are of economic importance to pharmaceutical, food and cosmetic industries. 
Nutraceuticals from grape seeds have potential cardioprotective, anti-cancer, antioxidant, 
anti-inflammatory, antiviral, neuroprotective, hepatoprotective and antimicrobial proper-
ties. Grape seed nutraceuticals have been re-invented in the past few years as a new para-
digm in human medicine. In particular, nutraceuticals from grape seeds have been used in 
stopping wound bleeding, anti-inflammatory agents, pain relief, and anti-diarrhea. In addi-
tion, they can be used for the treatment of various human health conditions such as cancer, 
cholera, smallpox, and nausea as well as eye infections, skin, kidney, liver diseases, etc. 
Nowadays, consumers are demanding for healthy supplements and personal care products 
with natural ingredients. Therefore, the present review highlights recent developments and 
future opportunities of grape seed nutraceuticals for the prevention of human diseases.
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1. Introduction
Grape (Vitis spp.) is one of the most economically important fruit crops worldwide [1]. Grapevine 
has a rich diversity, as reflected by global variations between wines from different continents or 
adjacent vineyards. These differences can be attributed to geographical locations, diversity in 
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climate conditions, or by human interventions arising from breeding and other vineyard man-
agement practices. Grapes are consumed fresh as table fruits or raisins and can be processed 
into wine, jam, jelly, grape seed oil, vinegar, grape seed extracts (GSE) and other products [1, 2]. 
The quality of grape products depends on a wide range of factors such as variety, environ-
mental conditions, viticultural practices and, more importantly, chemical properties of their 
secondary metabolites [1]. Secondary metabolites found in grape seeds include phytochemicals 
such as flavonoids, which are a group of natural polyphenols derived from phenylpropanoid 
pathway [2]. The stability of secondary metabolites may be impacted by external factors, such 
as environmental conditions (pH, light, temperature, etc.), due to the nature of physiological 
functions in growth and development of grapevines [3, 4]. Grape seeds contain phytochemicals 
such as alkaloids, terpenes, volatile oils, resins, glycosides, tannins, sterols, saponins, and phe-
nolics. These polyphenols have important applications in pharmaceutical, agrochemical, food, 
and cosmetic industries [1, 5, 6]. More importantly,  phenolic compounds are key determinants 
of wine quality such as aroma, color, and taste and are collectively referred to as organoleptic 
characteristics of grape products [7, 8]. For example, the quality of grape products is charac-
terized by polyphenolic  compounds such as flavonoids and anthocyanins. These natural mol-
ecules are generated through specific biosynthetic pathways in grapes.
Flavonoids are primarily located in the epidermal layer of berry skin and seeds in grapes [9]. 
They have biological attributes such as cytotoxicity and antioxidants, and their  biochemical 
properties play important functions in the defense against biotic and abiotic stresses in grape-
vines [10, 11]. These phenolic-rich compounds are potential nutraceuticals with biological 
properties for treatment and/or prevention of various human diseases, whereby they can be 
used as antioxidants, anti-inflammatory, and antimicrobial agents. Application of nutraceu-
ticals from grape seeds in human health is not new, because wine has been used for medici-
nal purposes since the medieval period. However, it has reemerged as an important field 
of human medicine and human nutrition in the past few years [12]. For instance, ethanol in 
“alcoholic” beverages has potential application in human health due to its properties in inhi-
bition of platelet aggregation, eicosanoid biosynthesis, and an antioxidant for free radicals 
[13]. Hence, it is important to analyze and characterize grape seed products for biochemical 
composition, biological activity, and bioavailability of phytochemicals and investigate their 
correlation to human health.
2. History and establishment of grapes in North America for food and 
wine industries
Domesticated crops appeared after the Neolithic period (4000–1000 BC) and included grape 
varieties that were selected for wine production, because they were easier to propagate and 
had higher proportion of flesh compared to seeds. Wine production from grape has been part 
of human culture for nearly 6000 years, with the earliest evidence dating back to between 7000 
and 5000 BC. Wine produced from grapes was used in dietary  applications, medicine, and 
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socioreligious activities. The earliest known winemaking facility, or at least its development, 
was considered to be in the Caucasus Mountains (4100–4000 BC), near the village of Areni 
in Southern Armenia. The region is considered as the  origin of domesticated wine grapes 
(Vitis vinifera) [13]. However, the transfer of winemaking knowledge and technology has been 
 somewhat linear, as it moved from Western Asia to Eastern Mediterranean region such as 
Egypt, Greece, and Southern Italy, before reaching the rest of Europe c.a. 2000 years ago. 
Today, for instance, wine grape is produced in every continent worldwide, and its chemi-
cal composition is profoundly influenced by factors such as improved enological techniques, 
region-specific grape cultivars, and local climatic conditions [13, 14]. The development of 
grape production and winemaking methods has been parallel to the overall technological 
advances, which came after Western civilization. There has been tremendous progress made 
in grape production, especially with respect to vine cultivation, vinification equipment, 
and winemaking practices such as fermentation, as compared with those used during the 
Neolithic era, including contemporary Egypt, ancient Greece, Western Asia, Ancient Israel, 
or the Roman Empire. These techniques plateaued around 200–400 AD and was followed 
by a period of between 1200 and 1400 years when the progress of wine technology slowed 
down and was generally restricted to monastic religious orders of Western Europe [15]. Wine 
 production methods increased during the eighteenth century, and the phenomenon was 
likely due to positive changes in trade relations in Europe, which led to increased demand for 
vintage and age-worthy wines associated with higher quality [15].
Wine production began to expand during the seventeenth century, whereby North Americans 
became latecomers to join the viticulture industry after the arrival of the first European 
 settlers. This was catapulted in part by the quest of the British government to produce its own 
wine in North America instead of France. The Franciscan missionaries planted the first large-
scale vineyards in California c.a. 200 years ago and reestablished them shortly after the repeal 
of prohibition [16]. However, the “Great French Wine Blight” that originated from California 
vineyards in the 1850s almost wiped out the European grape production. Grape phylloxera, 
Phylloxera vitifoliae, was transported to Europe on infected California rootstocks, and the pan-
demic almost wiped out c.a. 2.5 million acres of vineyards in France alone. The tide turned 
around when vineyards in Europe were replanted with V. vinifera grafted on Phylloxera-
resistant rootstocks, V. labrusca, a fox grape species native to the eastern North America [13].
With the rapid advancement of science, it was only natural that research on grapes with focus 
on value addition became such a huge subject worldwide. This led to increased demand for 
improved quality attributes such as wine color, flavor, and chemical composition of phe-
nolic compounds as well as the growth of wine and grape associated-food industries. High 
demand for vintage and/or age-worthy wines led to increased research in wine and other 
grape products. The high demand for quality was driven by the fact that wine became an 
integral part of human lifestyle from various cultural backgrounds worldwide. For exam-
ple, wine- and grape-related products were used during social events in many countries, 
whereas in a few other places, these products were used for either religious practices or 
medicinal purposes.
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3. Grape seed polyphenols and their benefits to human health
Grape seeds contain polyphenol-rich phytochemicals such as proanthocyanidins (oligomeric 
flavonoids), flavonoids (catechin, epicatechin, and quercetin), and anthocyanins. They also 
contain non-flavonoids such as hydroxycinnamic acids (p-coumaric, cinnamic, caffeic, gen-
tisic, ferulic, and vanillic acids) and hydroxybenzoic acids: trihydroxy stilbenes (resveratrol 
and polydatin) as well as vitamin E [12, 13, 17–19]. These secondary metabolites are respon-
sible for blue, purple, and red colors in many plant tissues. Also, grape seeds are rich in pro-
anthocyanidins, which are oligomeric anthocyanins [20, 21], and a few monomeric flavonoids. 
Previous studies indicated that these extracts could be used as supplements [22]. The poly-
phenols from grape seeds are potent antioxidants (Figure 1) that can protect the body from 
wide range of health conditions such as premature aging, numerous diseases, and decay [23]. 
During winemaking process, polyphenols from grape seeds can also infiltrate into wine prod-
ucts. Therefore, moderate wine consumption has been associated with reduced mortality from 
coronary heart disease, because it increases high-density lipoprotein (HDL) cholesterol con-
tent and, as a result, inhibits platelet aggregation [13]. The antioxidant effects of red wine and 
its major polyphenols have been demonstrated in many experimental systems spanning from 
in vitro studies (human low-density lipoprotein, liposomes, macrophages, cultured cells) to 
in vivo involving animal models as well as healthy human subjects [13].
 Figure 1. Muscadine grape seeds and their beneficial effects to human health.
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4. Chemical composition
Research in the chemical composition of grape and wine has advanced greatly in the past 
30–40 years. Currently, more than 500 compounds have been identified from wine, out of 
which 160 of these phytochemicals are esters. Each individual compound may be either insig-
nificant or has no role in human organoleptic (taste) perception, but collectively contribute to 
wine taste [13]. In grape seeds, the primary compounds such as water, ethanol, organic acids, 
sugars, and glycerol are present at high concentrations (>100 mg/L), and the rest are polyphe-
nols. These polyphenols are particularly large and complex group of compounds, which are 
key determinants of quality of red wines. The identification of  phenolic compounds in grapes 
and wine began in the late nineteenth century [15]. Previous studies indicated that grapes 
contain phytochemicals with antioxidant properties [16, 23].
Chemically, polyphenols are cyclic benzene compounds that contain one or more hydroxyl 
groups associated directly with the hydroxy-substituted benzene ring structure such as cat-
echins, resveratrol, cyanidin (Figure 2), and proanthocyanidins, which are oligomers of resve-
ratrol, catechin, and epicatechin.
The two primary groups of polyphenols that occur in grape seeds and wine are flavonoids 
and non-flavonoids. Flavonoids have been characterized as molecules possessing two phe-
nols, which are joined by a pyran (oxygen containing) carbon ring structure. They have a 
distinct C
6
-C
3
-C
3
 three-ring structure. The most common flavonoids in wine are flavanols 
(flavan-3-ols), which are the building block of grape tannins; whereas anthocyanins are pre-
dominantly present in red wines. Flavan-3-ol monomers (catechin) are responsible for the bit-
terness in wine and are associated with astringency in wine. The major flavan-3-ol monomers 
found in grapes and wine include (+)-catechin, (−)-epicatechin, and (−)-epicatechin-3-O-gal-
late [24]. Flavonoids are primarily from the skins, seeds, and stems of the fruit. Grape tannins, 
which are polymers of flavanols, are also known as condensed tannins or proanthocyani-
dins. Proanthocyanidins contribute to the complexity of wine taste and mouthfeel. Flavanol 
monomers and oligomers (links of two to four monomers) contribute to the bitterness, and 
their polymers contribute to astringency in wine. There are five anthocyanidins (cyanidin, 
peonidin, delphinidin, petunidin, and malvidin) in grapes. Anthocyanin with sugar bound 
 Figure 2. Structures of common healthy compounds found in grape seeds: (A) catechins, (B) resveratrol, and (C) cyanidin.
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to the anthocyanidin moiety may be acylated (acid linked to the sixth position of the sugar) 
such as acetic, coumaric, and caffeic acids. Flavonols (kaempferol, quercetin, and myricetin) 
are present in grape seeds and wine and are esterified to sugars to form glycosides. Flavonols 
are important cofactors for color enhancement. They also act as a natural sunscreen in the skin 
of grape berries.
Non-flavonoids have either C
1
-C
6
 or C
3
-C
6
 structures, meaning that either one carbon or three 
carbons are attached to the primary benzene ring (six carbons). The majority of the non-fla-
vonoids found in grapes are phenolic acids: hydroxycinnamic acids or hydroxycinnamates 
(esterified with tartaric acid: caftaric acid, coutaric acid, and fertaric acid), hydroxybenzoic 
acids (gallic acid, a hydrolysis product from grape or oak tannins), and stilbenes (resveratrol 
and piceid). They are predominantly present in pulp of grapes and are the major phenolic 
compounds in white wine  [15]. Previous studies indicated that non-flavonoids are produced 
in the grape berry before veràison [25]. Polymerization of polyhydroxy flavan-3-ol units, 
(+)-catechin and (−)-epicatechin, and their gallate esters produces oligomers and polymers 
called proanthocyanidins. Resveratrol is mainly found in the grape skin, whereas proan-
thocyanidins are found in the seeds [26]. Previous studies indicated that these compounds 
are high in seed material [27] and are  produced before veràison and change during fruit 
ripening [15]. Tannins on grapes protect wine against oxidation, stabilize wine color, and 
enhance mouthfeel [13]. Proanthocyanidins are members of a class of compounds described 
as anthocyanogens, leucoanthocyanidins, flavan-3,4-diols, condensed tannins, and tan-
nins [15]. Proanthocyanidins are polymers of flavan-3-ol subunits, meaning that they have a 
wide range of molecular weight. These phenolic compounds mainly impact the astringency 
in red wines, and they have been extracted from the skin, seeds, and stems of the grape 
berry. Recent studies demonstrated that proanthocyanidins (flavonoids) are some of the 
major  compounds present in grapes and wines.
Flavonoids are a class of secondary plant phenolics with significant antioxidant and  chelating 
properties. For example, their cardioprotective characteristics stem from their inhibition 
of lipid peroxidation, chelation of redox-active metals, and attenuation of reactive oxygen 
 species [28]. Primarily flavonoids occur in food polymers that are degraded to variable extents 
in the digestive tract. Although metabolism of these compounds has remained elusive, it has 
been established that their enteric absorption is correlated to reduction in reactive oxidative 
species in blood plasma [28]. The propensity of flavonoids to inhibit free radical activities 
is mediated by their chemical structure. However, their physical properties such as flavan 
nucleus,  number, positions, and types of substitutions are considered to play a major role in 
their  radical scavenging and chelating activity [28].
Structures of common anthocyanins were identified from V. vinifera and were determined 
wine in 1959. It was noted that malvidin-3-O-glucoside was a major grape anthocyanin and 
was present along with its acylated forms [15]. Similarly, it was noted that anthocyanins 
from V. vinifera showed different structural compositions to those isolated from non-vinifera 
 species, because they were exclusively monoglucosides and those in non-vinifera species were 
present as 3,5-diglucosides [15]. Because of the unique hue manifestation of both grape and 
wine phenolics, several studies have been performed on anthocyanins as compared to other 
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compounds [15]. These studies have focused on understanding the changes in anthocyanidins 
in respect to berry development [29], potential impact of cultural practices on production [30], 
and techniques for their extraction from wine and/or grape seed extracts [31].
5. Biological activities
Grape seed products are nutraceutical agents commonly consumed as a health/dietary sup-
plement or are sold as nutrition supplements (100–500 mg). Grape seeds are rich sources 
of catechins and procyanidins, which are present in red wine and grape juice. Previous 
studies indicated that these compounds have shown potent antioxidant activities [32–34] 
and scavenging activity against free radicals [35–38]. The antioxidant capacity of grape 
seed extracts is considered to perform better compared with vitamins C and E [39]. It was 
reported that procyanidins inhibited platelet aggregation [40] and had also successfully 
inhibited the  oxidation of low-density lipoprotein (LDL) as well as contributed to reduc-
tion in risks of heart disease associated with atherosclerosis [41]. In addition, procyanidins 
performed very well as anti-inflammatory [42, 43], antimutagens [44], anticancer [45–47], 
and antiviral [48] agents.
Grape seed extracts are potential antimicrobial for disease control [49] and can be used in 
food preservatives to ensure food safety [50]. Currently, there has been growing interest on 
the use of natural antibacterial compounds, such as herbal-based extracts for the preserva-
tion of foods, because they possess a unique characteristic flavor and have shown antioxidant 
and antimicrobial activities [51]. In general, grape seed extracts can be used as antibiotics, 
antidiarrhea, antiulcer, and anti-inflammatory agents [52, 53]. For example, the mechanism 
behind their antiulcer is considered to be due to their ability to protect the stomach wall from 
injuries caused by free radicals as well as the ability of procyanidins to bind other protein 
targets [53]. Flavonoids have shown success as antiulcer agents, because their suppressive 
effect depends on the presence of procyanidin oligomers. Previous studies indicated that 
procyanidins such as catechin oligomers significantly reduced gastric mucosal damage [53]. 
Furthermore, the binding ability of procyanidin oligomers to bind bovine serum albumin got 
strengthened in acidified solution. Thus, understanding the biosynthesis of these phenolic 
compounds may be important to efficiently manage their production as well as insure their 
bioavailability after wine production. However, it is important to further explore the in vivo 
potential activities of these secondary metabolites from grape seed extract, to determine their 
potential pharmacological applications in human medicine.
6. Health benefits
Grape seed extracts have potential to be used as nutraceuticals [46, 54]. For instance, red wine 
constitutes a reliable and rich source of biologically active phytochemicals, such as  phenolic 
acids and polyphenols, whose individual and summated actions are believed to confer health 
benefits in humans. Epidemiologic studies revealed that individuals with the habit of daily 
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moderate wine consumption can experience significant reductions in ill-health conditions, 
including those leading to cardiovascular mortality as compared with individuals who 
either abstain from drinking or consume excess alcohol [55]. Moderate consumption of wine, 
for example, was implicated in reduced atherosclerosis cardiovascular heart disease in the 
French population [56]. Heart disease is lower among the French (who have a relatively high 
red wine intake) as compared with other Europeans, despite their propensity to consume 
foods known to be rich in cholesterol, which was referred to as the “French paradox” due to 
their low incidence of coronary heart disease. Previous studies determined that drinking one 
to two glasses of wine a day can help protect against heart disease. In addition, phenolics in 
grapes and red wines have been demonstrated to inhibit oxidation of human low-density 
lipoproteins (LDL) in vitro [57]. Hence, researchers are working toward understanding both 
molecular and nutritional basis for these anecdotal observations. Although the benefits of 
polyphenols from fruits and vegetables is gaining ground on how they are making significant 
contribution to human health, but consensus toward increasing the rate of wine consumption 
is developing quite slowly [55]. This could be due to the negative perception that a huge seg-
ment of the society has toward alcohol consumption.
Recently, plant polyphenols have generated increased attention due to their potent antioxi-
dant properties and ability to prevent various diseases associated with oxidative stress [58]. 
This led to identification and development of phenolic compounds or extracts from different 
plants with health and related medical applications in the past few years. Medicinal and nutri-
tional values of grapes have been known to exist for thousands of years. For example, several 
ancient Greek philosophers exalted the healing power of wine from grapes, and in places, 
such as Ancient Egypt, wine was mythologically considered as “The Gift of Osiris.” They also 
used wine as a solvent for other medicinal products and in combination with other medicines 
(“polypharmacy”), and wine has been used in prescriptions dating back to between 3400 and 
2550 BC [59]. More importantly, wine was at the core of Mediterranean civilization and was 
the basis of vast seaborne trade that contributed to the spread of Greek civilization beginning 
the sixth century, including western Asia Minor, southern Italy, Sicily, North Africa, southern 
France, and Spain [59]. Wine was held in high esteem by the Persians because of its fame as a 
cure, which was epitomized by the oldest desert proverb: “He that has health has hope; and 
he that has hope, has everything.” Through the medieval period, the conversion of grapes into 
wine was considered as a gift from the gods, and the best wines were mainly preserved for 
ruling elite of the society, although the latter may have been associated with the high cost of 
wine. In addition, wine was used for medicinal purposes during the medieval period in areas 
such as ancient India in 2000 BC, ancient China in the past 5000 years, and ancient Rome after 
146 BC as well as during the era of Biblical Jewish and Arabic period [59]. The rich history of 
wine provides an insight of its benefit to human health for several years. It is, therefore, the 
reason why modern science continues to explore benefits of grape seeds as nutraceuticals 
with the potential to revolutionize modern human medicine.
To date, various parts of grape are known to confer therapeutic benefits in humans. For 
example, grape leaves can be used to alleviate wound bleeding, inflammation, muscle pain, 
and diarrhea; whereas unripe grapefruits are recommended for the treatment of sore throat. 
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Raisins (dried grape fruits) can be used to provide relief against constipation and are recom-
mended for treatment of human diseases, including anemia in pregnant women. In addi-
tion, ripe and sweet grapes can be used for treatment of diseases such as cancer, cholera, 
 smallpox, nausea, and eye infections as well as can provide relief against skin, kidney, and 
liver  disorders [23]. Grape extracts are rich in bioflavonoids (procyanidins) and are some of 
the most commonly consumed dietary supplements in the United States due to their poten-
tial health benefits. Previous studies indicated that grape extracts are beneficial to human 
health, because they have showed some efficacy against several diseases such as prostate 
carcinoma, which causes prostate cancer in men; cardiovascular-related conditions such as 
hypertension; vascular fragility; and other health conditions such as allergies, hypercho-
lesterolemia, LDL-cholesterol oxidation, and platelet aggregation disorder [60–63]. Other 
studies have showed that grape extracts can be used as therapeutic agents against diabetic 
cardiomyopathy [64].
Phenolic compounds such as catechin, quercetin, and resveratrol been known to promote the 
production of nitric oxide by vascular endothelium cells and, as a result, inhibit biosynthesis 
of thromboxane in platelets and leukotriene in neutrophils demonstrated to modulate biosyn-
thesis and secretion of lipoproteins in animal models and human cell lines, and arrest tumori-
genesis and subsequent carcinogenesis [13]. However, lack of statistical  correlation between 
wine consumption and lower rates of atherosclerosis has made it difficult to resolve the key 
question of whether moderate consumption may likely lead to decreased  atherosclerotic mor-
tality [55]. However, some studies have suggested that there is a relationship between wine 
consumption and atherosclerotic mortality, which may likely be associated with its direct 
effect on lipoprotein metabolism.
Moderate ethanol intake is not generally contraindicated in diabetes, although diabetic 
patients have showed high risk for atherosclerotic cardiovascular disease [65], initiated 
from oxidative damage of glycosylated proteins and lipids [66–68]. Thus, diabetics as well 
as nondiabetics are likely to benefit from moderate ethanol intake, because it can help ame-
liorate risk factors associated with atherosclerotic heart disease that arise from lipoprotein 
metabolism. Although little information is available on the effects of polyphenols in wine 
and related grape seed products on diabetics, there may be confounding lifestyle variables 
associated with spontaneous wine consumption, such as reduced smoking, increased exer-
cise frequency, and better dietary habits that mimic general recommendations given to dia-
betic patients [55].
7. Bioavailability
Some flavonoids found in wine, such as tannins, are in the form of polymers that may not read-
ily break down under physiological conditions and may not be expected to be available for 
absorption [69]. Conversely, for non-tannin flavonoids in red wine, about half are present as 
glycosides, and the rest are present as aglycones (glycosyl group replaced by hydrogen). It has 
been shown that flavan-3-ols, flavonols, anthocyanins, and non-flavonoid stilbenes, which are 
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present in red wine and related grape products, can be absorbed in the gastrointestinal tract 
[55]. Previous studies reported that anthocyanin pigments, which are  responsible for the red 
color of wine, were found in human urine [70] and human plasma [71] after wine consump-
tion. Most glycosides that pass into the large intestine generally end up being hydrolyzed 
by fecal microflora, rendering them as free aglycones, which leads to their poor absorption 
in the small intestines. Resveratrol, a non-flavonoid trihydroxystilbene, which is a relatively 
minor component of red wine [72], is present at insignificant low levels in white wines [55, 73]. 
However, long-term wine consumption can increase tissue-specific resveratrol concentrations 
in the body [74].
Flavonoids can travel in the body while bound to plasma proteins [75, 76]. The metabolism 
of flavonoid glycosides to aglycones and specific glucuronides occurs in the intestinal tissue, 
which depends on the structure of the flavonoid [77]. The metabolism of esterified flavonoids 
to aglycones leads to increased lack of absorption in the small intestine. However, conjugated 
derivatives of quercetin have retained partial antioxidant activity, and it has been demon-
strated that different combinations of these conjugates have potential additive effects [78]. 
Phenolic acids and polyphenols possess multiple hydroxyl groups and are subject to further 
metabolism by enzymes in the intestine, liver, and kidney [79, 80]. However, the main draw-
back is that other important nutraceuticals may not be fully absorbed in the human body. 
Besides, bioavailability under in vivo conditions needs to be resolved as well as their absorp-
tion in the gastrointestinal tract in order to keep them at sustainable pharmacokinetic levels 
in the blood system.
8. Safety concerns for application of grape seed products from American 
native grapes in foods and cosmetics
Today, consumer demand for health supplements as well as personal care products with 
natural and/or organic ingredients is promising. Consumption of a large amount of grapes 
and related products, such as wine, has contributed to the low risk of chronic diseases, such 
as coronary heart disease and certain cancers [81]. Grape seed extract, which is primarily a 
mixture of proanthocyanidins, has been shown to modulate a wide range of biological, phar-
macological, and toxicological effects as well as cytoprotective functions. Previous  studies 
investigated the ability of IH636 from grape seed proanthocyanidin extract (GSPE) for the 
prevention of acetaminophen (AAP)-induced nephrotoxicity, amiodarone (AMI)-induced 
lung toxicity, and doxorubicin (DOX)-induced cardiotoxicity in mice [82]. However, there are 
safety concerns on the use of these natural products in humans.
Probably one of the best-known properties of polyphenolic compounds, which may also be 
of safety concern, is their binding and precipitation of protein targets [52]. Most polyphe-
nols have the capacity to bind proteins because of their high affinity for hydroxylation, that 
is, introduction of hydroxyl groups on other essential biological compounds. Conversely, 
low-molecular-weight phenols lack the ability to precipitate proteins, unless their oligomeric 
composition has at least three flavonol subunits, which may mainly be found on highly 
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polymerized tannin molecules. Tannin-protein complexes arise from interactions between 
hydrogen molecules and hydrophobic moieties without the participation of their respective 
covalent or ionic bonds [52]. The safety of plant products may vary due to several factors 
such as geographical origin, growth conditions, and other production processes [83]. It is 
therefore important to conduct studies to characterize these phytochemicals from plant-based 
 products, in order to investigate whether they are safe for use by humans.
To date, there are no conclusive studies on contraindication of grape products for either 
treatment or prevention of human diseases as well as their use in cosmetics. However, 
recent studies suggest that grape seed products may be safe for treatment of important 
human diseases. For example, in one particular study which involved the administration 
of grape seed extract (GSE) as a dietary admixture at levels of 0.02, 0.2, and 2% (w/w) 
to rats for 90 days, it was demonstrated that GSE showed no toxicity. Results indicated 
lack of toxicity, which supported the use of proanthocyanidin-rich grape seed extracts [22]. 
Similarly, in a different study that the administration of GSE IH636 to male and female 
Sprague-Dawley rats in the feed at levels of 0.5, 1.0, or 2.0% for 90 days, it was reported 
there were no significant  toxicological effects [84]. Besides, Wren and colleagues found no 
significant changes in clinical signs, hematological parameters, organ weights, ophthalmol-
ogy evaluations, or histopathology, and identical results were reported from a different 
study that was conducted on IGS BR rats, which were fed with dietary supplements of 
GSE at concentrations of 0, 0.63, 1.25, or 2.5% (w/w), which found lack of adverse effects on 
mouse models [85].
These studies pointed to lack of toxicity and supported the use of proanthocyanidin-
rich extracts from grape seeds, except for personal care products, in which there has been 
some evidence for minimal side effects on the skin surface such as irritation, sensitization, 
 phototoxicity, and immediate-type allergy [86].
9. Conclusions and future remarks
Phenolic compounds found in grape seeds have desirable biological activities, which are 
related to their antioxidant properties. These compounds have the ability to scavange for 
free radicals and inhibit non-desirable enzymatic activities, including the modulation of 
 essential biosynthetic pathways for the metabolism of cellular and extracellular products 
such as membrane proteins and lipids. Moderate consumption of red wine, for example, 
can lead to increased plasma concentrations of HDL cholesterol and decreased adhesion of 
platelets, which may be beneficial to treating platelet aggregration in humans. Biosynthesis 
of pro-aggregatory eicosanoids such as thromboxane A
2
 and synthesis of leukocytes by pro-
inflammatory leukotrienes to inhibit the formation of atherosclerosis can reduce the risk of 
coronary arterial disease by promoting the relaxation of vascular smooth muscle [16, 87]. In 
addition, some polyphenols are capable of promoting the synthesis of prostacyclin (prosta-
glandin member of eicosanoids) and nitric oxide, which can lead to optimized blood flow 
through the arterial system [13].
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Use of nutraceuticals from grape seeds for the mitigation of grape diseases for which bio-
markers are known have not been validated. Although nutraceuticals have shown a great 
promise in the treatment and/or prevention of human diseases, consensus on their wide 
acceptance as alternative therapeutic agents is developing very slowly. Previous studies 
demonstrated that nutraceuticals found in grape seeds likely have the ability to modulate 
cellular metabolism and signaling, which is consistent with reduced coronary arterial dis-
ease [16, 87]. However, additional research is needed to address crucial important issues 
such as the mechanisms by which phytochemicals in grape seeds can be used as nutraceuti-
cals, develop biomarkers for their role in disease prevention, and determine the appropriate 
dosage for their application in human health medicine.
There are still several gaps that need to be addressed. First, there should be a broad frame-
work for research to understand the mechanism by which polyphenols from grape seed prod-
ucts confer dietary health benefits to humans. Second, additional clinical studies are needed 
to determine their pharmacokinetic properties in human disease prevention. Third, appropri-
ate biomarkers or mechanistic end points should be developed to determine the interactions 
between diseases and polyphenols at cellular and subcellular levels. Lack of adequate clinical 
data on nutraceuticals from grape seed products precludes their use in human health. First, it 
is not known whether the benefit of red wine originates from the tendency to consume them 
during meal time, or their consumption together with other macronutrients improves their 
absorption in the gastrointestinal tract. Second, it is not known whether the ability of wine 
to scavenge for free radicals originates from its chemical properties as a biofuel, through its 
ability to cause oxidative stress, or using both mechanisms, which may suggest that it has 
multiple effects at the cellular or subcellular level.
The success of human genome project and recent developments in molecular biology has led 
to major revolution in biological sciences. Thus, the application nutraceuticals from grape 
seeds to human health need to be prioritized as one of the areas of current research. Additional 
research should focus on understanding potential effects of confounding factors that may be 
associated with the use of nutraceuticals from grape seeds. This is because preliminary data 
suggest that nutraceuticals from grape seeds have valuable applications in the prevention 
and/or treatment of several human diseases. Hence, there are unlimited opportunities pre-
sented by the application of polyphenols from grape seeds as nutraceuticals. Therefore, it is 
important to investigate not only their bioavailability and chemical composition but also to 
characterize their biological properties to determine their mechanisms as well as their syner-
gistic properties and other components of human diet.
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